Currently out of the existing stock ratings of Brandon Henry, 28 are a BUY (51.85%), 26 are a HOLD (48.15%).

Brandon Henry

Work Performance Price Targets & Ratings Chart

Analyst Brandon Henry, currently employed carries an average stock price target met ratio of 89.77% that have a potential upside of 16.44% achieved within 285 days. Previously, Brandon Henry worked at RBC.

Brandon Henry’s has documented 89 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on PEN, Penumbra at 18-Jul-2022.

Wall Street Analyst Brandon Henry

Analyst best performing recommendations are on PEN (PENUMBRA).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 4/18/2018. The price target of $153.33 was fulfilled within 2 days with a profit of $3.68 (2.34%) receiving and performance score of 11.72.

Average potential price target upside

of $45.92 (35.69%) on PEN (PENUMBRA).
of $31.64 (31.77%) on JNJ (JOHNSON & JOHNSON).
of $21.59 (24.31%) on MDT (MEDTRONIC PLC).

ISRG Intuitive Surgical NUVA NuVasive SYK Stryker VAR Varian Medical Systems ZBH Zimmer Biomet Holdings BAX Baxter International MDT Medtronic PLC EW Edwards Lifesciences Corp JNJ Johnson & Johnson PEN Penumbra WMGI Wright Medical Group N.V

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

David Rescott (BAIRD)